IL-27 Inhibits Hyperglycemia and Pancreatic Islet Inflammation Induced by Streptozotocin in Mice
Authors:
- 1 November 2011
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 179 (5) , 2327-2336
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 34 references indexed in Scilit:
- Regulation of immune responses by interleukin‐27Immunological Reviews, 2008
- Amelioration of delayed-type hypersensitivity responses by IL-27 administrationBiochemical and Biophysical Research Communications, 2008
- Advances in understanding the anti-inflammatory properties of IL-27Immunology Letters, 2008
- New Members of the Interleukin‐12 Family of Cytokines: IL‐23 and IL‐27 Modulate Autoimmune DiabetesAnnals of the New York Academy of Sciences, 2006
- Interleukin 27 negatively regulates the development of interleukin 17–producing T helper cells during chronic inflammation of the central nervous systemNature Immunology, 2006
- Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17–producing T cellsNature Immunology, 2006
- IL‐23 leads to diabetes induction after subdiabetogenic treatment with multiple low doses of streptozotocinEuropean Journal of Immunology, 2005
- THE NOD MOUSE: A Model of Immune DysregulationAnnual Review of Immunology, 2005
- A Comprehensive Analysis of Cytokine-induced and Nuclear Factor-κB-dependent Genes in Primary Rat Pancreatic β-CellsJournal of Biological Chemistry, 2001
- Interleukin-1 Receptor Antagonist Prevents Low-Dose Streptozotocin-Induced Diabetes in MiceBiochemical and Biophysical Research Communications, 1994